nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—KDR—malaria	0.323	1	CbGaD
Sorafenib—CYP2B6—Artemether—malaria	0.0188	0.0446	CbGbCtD
Sorafenib—CYP2C8—Sulfadiazine—malaria	0.0167	0.0398	CbGbCtD
Sorafenib—CYP2C8—Pyrimethamine—malaria	0.0167	0.0398	CbGbCtD
Sorafenib—ABCC2—Quinidine—malaria	0.0157	0.0374	CbGbCtD
Sorafenib—CYP3A5—Artemether—malaria	0.0148	0.0352	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Quinine—malaria	0.0119	0.0284	CbGbCtD
Sorafenib—CYP3A7—Quinine—malaria	0.0119	0.0284	CbGbCtD
Sorafenib—CYP2C19—Artemether—malaria	0.0119	0.0284	CbGbCtD
Sorafenib—CYP3A4—Clindamycin—malaria	0.0118	0.0281	CbGbCtD
Sorafenib—CYP2C9—Pyrimethamine—malaria	0.0117	0.0277	CbGbCtD
Sorafenib—CYP2C9—Sulfadiazine—malaria	0.0117	0.0277	CbGbCtD
Sorafenib—CYP2C19—Proguanil—malaria	0.0112	0.0267	CbGbCtD
Sorafenib—CYP2D6—Pyrimethamine—malaria	0.0107	0.0254	CbGbCtD
Sorafenib—CYP3A7—Quinidine—malaria	0.0105	0.025	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Quinidine—malaria	0.0105	0.025	CbGbCtD
Sorafenib—CYP1A2—Proguanil—malaria	0.0104	0.0246	CbGbCtD
Sorafenib—CYP2B6—Quinidine—malaria	0.01	0.0238	CbGbCtD
Sorafenib—CYP2C9—Artemether—malaria	0.00992	0.0236	CbGbCtD
Sorafenib—CYP2C9—Proguanil—malaria	0.00933	0.0222	CbGbCtD
Sorafenib—CYP2D6—Artemether—malaria	0.00907	0.0216	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Dapsone—malaria	0.00906	0.0215	CbGbCtD
Sorafenib—CYP3A7—Dapsone—malaria	0.00906	0.0215	CbGbCtD
Sorafenib—CYP3A5—Quinine—malaria	0.00896	0.0213	CbGbCtD
Sorafenib—CYP2C8—Quinine—malaria	0.00862	0.0205	CbGbCtD
Sorafenib—CYP2D6—Proguanil—malaria	0.00853	0.0203	CbGbCtD
Sorafenib—CYP2D6—Quinidine barbiturate—malaria	0.00809	0.0192	CbGbCtD
Sorafenib—CYP2C8—Quinidine—malaria	0.00757	0.018	CbGbCtD
Sorafenib—CYP1A2—Pentoxifylline—malaria	0.00744	0.0177	CbGbCtD
Sorafenib—CYP2C19—Quinine—malaria	0.00723	0.0172	CbGbCtD
Sorafenib—CYP3A5—Dapsone—malaria	0.00679	0.0161	CbGbCtD
Sorafenib—CYP3A4—Sulfadiazine—malaria	0.00679	0.0161	CbGbCtD
Sorafenib—CYP1A2—Quinine—malaria	0.00667	0.0159	CbGbCtD
Sorafenib—CYP2C8—Dapsone—malaria	0.00653	0.0155	CbGbCtD
Sorafenib—CYP2C9—Quinine—malaria	0.00601	0.0143	CbGbCtD
Sorafenib—CYP1A2—Quinidine—malaria	0.00586	0.0139	CbGbCtD
Sorafenib—ABCB1—Quinine—malaria	0.00583	0.0139	CbGbCtD
Sorafenib—CYP3A4—Artemether—malaria	0.00577	0.0137	CbGbCtD
Sorafenib—CYP2D6—Quinine—malaria	0.0055	0.0131	CbGbCtD
Sorafenib—CYP2C19—Dapsone—malaria	0.00548	0.013	CbGbCtD
Sorafenib—CYP3A4—Proguanil—malaria	0.00542	0.0129	CbGbCtD
Sorafenib—CYP2C9—Quinidine—malaria	0.00528	0.0126	CbGbCtD
Sorafenib—CYP3A4—Doxycycline—malaria	0.00514	0.0122	CbGbCtD
Sorafenib—ABCB1—Quinidine—malaria	0.00513	0.0122	CbGbCtD
Sorafenib—CYP2D6—Quinidine—malaria	0.00483	0.0115	CbGbCtD
Sorafenib—CYP2C9—Dapsone—malaria	0.00456	0.0108	CbGbCtD
Sorafenib—CYP3A4—Quinine—malaria	0.0035	0.00831	CbGbCtD
Sorafenib—CYP3A4—Quinidine—malaria	0.00307	0.0073	CbGbCtD
Sorafenib—Regorafenib—KDR—malaria	0.00277	1	CrCbGaD
Sorafenib—CYP3A4—Dapsone—malaria	0.00265	0.0063	CbGbCtD
Sorafenib—TIE1—endothelium—malaria	0.00158	0.0191	CbGeAlD
Sorafenib—FLT4—endothelium—malaria	0.0013	0.0158	CbGeAlD
Sorafenib—FLT3—blood plasma—malaria	0.00127	0.0154	CbGeAlD
Sorafenib—CDK7—Sulfathiazole—Sulfadiazine—malaria	0.00126	0.608	CbGdCrCtD
Sorafenib—FLT1—endothelium—malaria	0.00101	0.0123	CbGeAlD
Sorafenib—CDK7—hematopoietic system—malaria	0.00098	0.0118	CbGeAlD
Sorafenib—RALBP1—blood plasma—malaria	0.000946	0.0114	CbGeAlD
Sorafenib—FLT1—blood plasma—malaria	0.0009	0.0109	CbGeAlD
Sorafenib—KDR—endothelium—malaria	0.000857	0.0104	CbGeAlD
Sorafenib—STK10—blood plasma—malaria	0.000852	0.0103	CbGeAlD
Sorafenib—ZAK—hematopoietic system—malaria	0.000847	0.0102	CbGeAlD
Sorafenib—CDKL3—brain—malaria	0.000838	0.0101	CbGeAlD
Sorafenib—CDK7—Sulfathiazole—Dapsone—malaria	0.000814	0.392	CbGdCrCtD
Sorafenib—UGT1A1—blood plasma—malaria	0.000805	0.00973	CbGeAlD
Sorafenib—TIE1—hematopoietic system—malaria	0.000775	0.00936	CbGeAlD
Sorafenib—CDKL2—brain—malaria	0.000767	0.00927	CbGeAlD
Sorafenib—KDR—blood plasma—malaria	0.000761	0.0092	CbGeAlD
Sorafenib—KIT—endothelium—malaria	0.000759	0.00918	CbGeAlD
Sorafenib—CSF1R—blood plasma—malaria	0.000743	0.00898	CbGeAlD
Sorafenib—FLT3—hematopoietic system—malaria	0.000705	0.00852	CbGeAlD
Sorafenib—MAPK15—brain—malaria	0.00069	0.00835	CbGeAlD
Sorafenib—HIPK3—kidney—malaria	0.000679	0.00821	CbGeAlD
Sorafenib—KIT—blood plasma—malaria	0.000674	0.00815	CbGeAlD
Sorafenib—TAOK2—blood—malaria	0.000644	0.00779	CbGeAlD
Sorafenib—FLT4—hematopoietic system—malaria	0.00064	0.00774	CbGeAlD
Sorafenib—MAP3K7—saliva-secreting gland—malaria	0.000626	0.00757	CbGeAlD
Sorafenib—MKNK2—saliva-secreting gland—malaria	0.000607	0.00734	CbGeAlD
Sorafenib—ZAK—digestive system—malaria	0.000589	0.00712	CbGeAlD
Sorafenib—MKNK2—hematopoietic system—malaria	0.000579	0.007	CbGeAlD
Sorafenib—HIPK3—digestive system—malaria	0.000576	0.00697	CbGeAlD
Sorafenib—MKNK1—hematopoietic system—malaria	0.000572	0.00692	CbGeAlD
Sorafenib—RET—hematopoietic system—malaria	0.000565	0.00683	CbGeAlD
Sorafenib—ZAK—blood—malaria	0.000561	0.00678	CbGeAlD
Sorafenib—HIPK3—blood—malaria	0.000549	0.00664	CbGeAlD
Sorafenib—RALBP1—saliva-secreting gland—malaria	0.000548	0.00663	CbGeAlD
Sorafenib—UGT1A9—kidney—malaria	0.000532	0.00643	CbGeAlD
Sorafenib—HIPK3—bone marrow—malaria	0.000531	0.00642	CbGeAlD
Sorafenib—ABCC4—blood plasma—malaria	0.000524	0.00634	CbGeAlD
Sorafenib—RALBP1—hematopoietic system—malaria	0.000523	0.00633	CbGeAlD
Sorafenib—FLT1—saliva-secreting gland—malaria	0.000521	0.0063	CbGeAlD
Sorafenib—RAF1—saliva-secreting gland—malaria	0.000518	0.00627	CbGeAlD
Sorafenib—EPHB6—saliva-secreting gland—malaria	0.000515	0.00623	CbGeAlD
Sorafenib—CDK7—liver—malaria	0.000508	0.00614	CbGeAlD
Sorafenib—TAOK2—liver—malaria	0.000504	0.00609	CbGeAlD
Sorafenib—FLT1—hematopoietic system—malaria	0.000498	0.00602	CbGeAlD
Sorafenib—RAF1—hematopoietic system—malaria	0.000495	0.00598	CbGeAlD
Sorafenib—BRAF—blood—malaria	0.000492	0.00595	CbGeAlD
Sorafenib—BRAF—bone marrow—malaria	0.000476	0.00576	CbGeAlD
Sorafenib—STK10—hematopoietic system—malaria	0.000471	0.0057	CbGeAlD
Sorafenib—EPHX2—blood—malaria	0.00047	0.00568	CbGeAlD
Sorafenib—FLT3—blood—malaria	0.000467	0.00564	CbGeAlD
Sorafenib—PDGFRA—hematopoietic system—malaria	0.000466	0.00564	CbGeAlD
Sorafenib—HIPK4—brain—malaria	0.000465	0.00562	CbGeAlD
Sorafenib—RET—kidney—malaria	0.000463	0.0056	CbGeAlD
Sorafenib—FLT3—bone marrow—malaria	0.000452	0.00546	CbGeAlD
Sorafenib—UGT1A9—digestive system—malaria	0.000451	0.00546	CbGeAlD
Sorafenib—UGT1A1—hematopoietic system—malaria	0.000445	0.00538	CbGeAlD
Sorafenib—KDR—saliva-secreting gland—malaria	0.000441	0.00533	CbGeAlD
Sorafenib—MAP2K5—saliva-secreting gland—malaria	0.000441	0.00533	CbGeAlD
Sorafenib—ZAK—liver—malaria	0.000439	0.0053	CbGeAlD
Sorafenib—CYP2C19—blood plasma—malaria	0.000436	0.00527	CbGeAlD
Sorafenib—HIPK3—liver—malaria	0.000429	0.00519	CbGeAlD
Sorafenib—RALBP1—kidney—malaria	0.000429	0.00518	CbGeAlD
Sorafenib—FLT4—blood—malaria	0.000424	0.00513	CbGeAlD
Sorafenib—KDR—hematopoietic system—malaria	0.000421	0.00509	CbGeAlD
Sorafenib—CSF1R—hematopoietic system—malaria	0.000411	0.00496	CbGeAlD
Sorafenib—FLT4—bone marrow—malaria	0.00041	0.00496	CbGeAlD
Sorafenib—MAPK11—brain—malaria	0.000409	0.00495	CbGeAlD
Sorafenib—FLT1—kidney—malaria	0.000408	0.00493	CbGeAlD
Sorafenib—RAF1—kidney—malaria	0.000406	0.0049	CbGeAlD
Sorafenib—MKNK2—digestive system—malaria	0.000403	0.00487	CbGeAlD
Sorafenib—CDK7—brain—malaria	0.000403	0.00487	CbGeAlD
Sorafenib—TIE1—liver—malaria	0.000401	0.00485	CbGeAlD
Sorafenib—TAOK2—brain—malaria	0.0004	0.00483	CbGeAlD
Sorafenib—MKNK1—digestive system—malaria	0.000398	0.00481	CbGeAlD
Sorafenib—AURKC—brain—malaria	0.000397	0.00479	CbGeAlD
Sorafenib—MAP3K7—blood—malaria	0.000396	0.00479	CbGeAlD
Sorafenib—RET—digestive system—malaria	0.000393	0.00475	CbGeAlD
Sorafenib—KIT—saliva-secreting gland—malaria	0.000391	0.00472	CbGeAlD
Sorafenib—STK10—kidney—malaria	0.000386	0.00467	CbGeAlD
Sorafenib—BRAF—liver—malaria	0.000385	0.00465	CbGeAlD
Sorafenib—MKNK2—blood—malaria	0.000384	0.00464	CbGeAlD
Sorafenib—MAP3K7—bone marrow—malaria	0.000383	0.00463	CbGeAlD
Sorafenib—PDGFRB—saliva-secreting gland—malaria	0.000382	0.00461	CbGeAlD
Sorafenib—CYP2C8—blood plasma—malaria	0.000381	0.0046	CbGeAlD
Sorafenib—MKNK1—blood—malaria	0.000379	0.00458	CbGeAlD
Sorafenib—RET—blood—malaria	0.000374	0.00453	CbGeAlD
Sorafenib—KIT—hematopoietic system—malaria	0.000373	0.00451	CbGeAlD
Sorafenib—MKNK2—bone marrow—malaria	0.000371	0.00449	CbGeAlD
Sorafenib—EPHX2—liver—malaria	0.000368	0.00445	CbGeAlD
Sorafenib—EPHA6—brain—malaria	0.000367	0.00444	CbGeAlD
Sorafenib—MKNK1—bone marrow—malaria	0.000367	0.00443	CbGeAlD
Sorafenib—FLT3—liver—malaria	0.000365	0.00441	CbGeAlD
Sorafenib—UGT1A1—kidney—malaria	0.000365	0.00441	CbGeAlD
Sorafenib—PDGFRB—hematopoietic system—malaria	0.000364	0.0044	CbGeAlD
Sorafenib—RALBP1—digestive system—malaria	0.000364	0.0044	CbGeAlD
Sorafenib—CYP1A2—blood plasma—malaria	0.000356	0.00431	CbGeAlD
Sorafenib—ZAK—brain—malaria	0.000348	0.00421	CbGeAlD
Sorafenib—RALBP1—blood—malaria	0.000347	0.00419	CbGeAlD
Sorafenib—FLT1—digestive system—malaria	0.000346	0.00418	CbGeAlD
Sorafenib—KDR—kidney—malaria	0.000345	0.00417	CbGeAlD
Sorafenib—RAF1—digestive system—malaria	0.000344	0.00416	CbGeAlD
Sorafenib—CYP3A5—blood plasma—malaria	0.000344	0.00415	CbGeAlD
Sorafenib—CYP2B6—blood plasma—malaria	0.000341	0.00413	CbGeAlD
Sorafenib—HIPK3—brain—malaria	0.000341	0.00412	CbGeAlD
Sorafenib—CYP2C9—blood plasma—malaria	0.000338	0.00409	CbGeAlD
Sorafenib—UGT1A9—liver—malaria	0.000336	0.00407	CbGeAlD
Sorafenib—RALBP1—bone marrow—malaria	0.000335	0.00406	CbGeAlD
Sorafenib—MAP3K19—brain—malaria	0.000334	0.00404	CbGeAlD
Sorafenib—FLT4—liver—malaria	0.000332	0.00401	CbGeAlD
Sorafenib—FLT1—blood—malaria	0.00033	0.00399	CbGeAlD
Sorafenib—RAF1—blood—malaria	0.000328	0.00396	CbGeAlD
Sorafenib—STK10—digestive system—malaria	0.000328	0.00396	CbGeAlD
Sorafenib—FGFR1—liver—malaria	0.000327	0.00396	CbGeAlD
Sorafenib—EPHB6—blood—malaria	0.000326	0.00394	CbGeAlD
Sorafenib—PDGFRA—digestive system—malaria	0.000324	0.00392	CbGeAlD
Sorafenib—TIE1—brain—malaria	0.000318	0.00385	CbGeAlD
Sorafenib—RAF1—bone marrow—malaria	0.000317	0.00383	CbGeAlD
Sorafenib—STK10—blood—malaria	0.000312	0.00377	CbGeAlD
Sorafenib—MAP3K7—liver—malaria	0.00031	0.00374	CbGeAlD
Sorafenib—UGT1A1—digestive system—malaria	0.000309	0.00374	CbGeAlD
Sorafenib—PDGFRA—blood—malaria	0.000309	0.00374	CbGeAlD
Sorafenib—KIT—kidney—malaria	0.000306	0.00369	CbGeAlD
Sorafenib—BRAF—brain—malaria	0.000305	0.00369	CbGeAlD
Sorafenib—STK10—bone marrow—malaria	0.000302	0.00365	CbGeAlD
Sorafenib—MKNK2—liver—malaria	0.0003	0.00363	CbGeAlD
Sorafenib—PDGFRB—kidney—malaria	0.000298	0.00361	CbGeAlD
Sorafenib—MKNK1—liver—malaria	0.000296	0.00358	CbGeAlD
Sorafenib—UGT1A1—blood—malaria	0.000295	0.00356	CbGeAlD
Sorafenib—KDR—digestive system—malaria	0.000293	0.00354	CbGeAlD
Sorafenib—EPHX2—brain—malaria	0.000292	0.00353	CbGeAlD
Sorafenib—ABCC4—hematopoietic system—malaria	0.00029	0.00351	CbGeAlD
Sorafenib—CSF1R—digestive system—malaria	0.000286	0.00345	CbGeAlD
Sorafenib—CYP3A7—liver—malaria	0.00028	0.00338	CbGeAlD
Sorafenib—MAP2K5—blood—malaria	0.000279	0.00337	CbGeAlD
Sorafenib—KDR—blood—malaria	0.000279	0.00337	CbGeAlD
Sorafenib—Stevens-Johnson syndrome—Quinine—malaria	0.000277	0.00254	CcSEcCtD
Sorafenib—Renal failure—Quinidine—malaria	0.000274	0.00252	CcSEcCtD
Sorafenib—Renal failure—Quinine—malaria	0.000274	0.00252	CcSEcCtD
Sorafenib—CSF1R—blood—malaria	0.000272	0.00329	CbGeAlD
Sorafenib—Jaundice—Quinidine—malaria	0.000272	0.00249	CcSEcCtD
Sorafenib—Jaundice—Quinine—malaria	0.000272	0.00249	CcSEcCtD
Sorafenib—RALBP1—liver—malaria	0.000271	0.00328	CbGeAlD
Sorafenib—Abdominal discomfort—Pentoxifylline—malaria	0.00027	0.00248	CcSEcCtD
Sorafenib—KDR—bone marrow—malaria	0.00027	0.00326	CbGeAlD
Sorafenib—Epistaxis—Clindamycin—malaria	0.000268	0.00246	CcSEcCtD
Sorafenib—Leukopenia—Sulfadiazine—malaria	0.000267	0.00245	CcSEcCtD
Sorafenib—Neutropenia—Quinidine barbiturate—malaria	0.000264	0.00242	CcSEcCtD
Sorafenib—CSF1R—bone marrow—malaria	0.000263	0.00318	CbGeAlD
Sorafenib—FLT4—brain—malaria	0.000263	0.00318	CbGeAlD
Sorafenib—FGFR1—brain—malaria	0.00026	0.00314	CbGeAlD
Sorafenib—KIT—digestive system—malaria	0.000259	0.00313	CbGeAlD
Sorafenib—CYP3A4—blood plasma—malaria	0.000258	0.00312	CbGeAlD
Sorafenib—FLT1—liver—malaria	0.000258	0.00312	CbGeAlD
Sorafenib—RAF1—liver—malaria	0.000256	0.0031	CbGeAlD
Sorafenib—Arthralgia—Sulfadiazine—malaria	0.000254	0.00233	CcSEcCtD
Sorafenib—CYP2D6—blood plasma—malaria	0.000254	0.00307	CbGeAlD
Sorafenib—PDGFRB—digestive system—malaria	0.000253	0.00306	CbGeAlD
Sorafenib—Haemoglobin—Quinidine—malaria	0.000252	0.00231	CcSEcCtD
Sorafenib—Haemoglobin—Quinine—malaria	0.000252	0.00231	CcSEcCtD
Sorafenib—Infestation—Pentoxifylline—malaria	0.000251	0.00231	CcSEcCtD
Sorafenib—Infestation NOS—Pentoxifylline—malaria	0.000251	0.00231	CcSEcCtD
Sorafenib—Diarrhoea—Proguanil—malaria	0.000251	0.0023	CcSEcCtD
Sorafenib—Haemorrhage—Quinine—malaria	0.00025	0.0023	CcSEcCtD
Sorafenib—Haemorrhage—Quinidine—malaria	0.00025	0.0023	CcSEcCtD
Sorafenib—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.00025	0.00229	CcSEcCtD
Sorafenib—Renal failure—Quinidine barbiturate—malaria	0.000247	0.00227	CcSEcCtD
Sorafenib—Urinary tract disorder—Quinine—malaria	0.000247	0.00227	CcSEcCtD
Sorafenib—Urinary tract disorder—Quinidine—malaria	0.000247	0.00227	CcSEcCtD
Sorafenib—KIT—blood—malaria	0.000247	0.00299	CbGeAlD
Sorafenib—Tinnitus—Dapsone—malaria	0.000246	0.00226	CcSEcCtD
Sorafenib—MAP3K7—brain—malaria	0.000246	0.00297	CbGeAlD
Sorafenib—Urethral disorder—Quinine—malaria	0.000245	0.00225	CcSEcCtD
Sorafenib—Urethral disorder—Quinidine—malaria	0.000245	0.00225	CcSEcCtD
Sorafenib—Jaundice—Quinidine barbiturate—malaria	0.000245	0.00225	CcSEcCtD
Sorafenib—Jaundice—Pentoxifylline—malaria	0.000245	0.00225	CcSEcCtD
Sorafenib—STK10—liver—malaria	0.000244	0.00295	CbGeAlD
Sorafenib—Anaphylactic shock—Sulfadiazine—malaria	0.000244	0.00223	CcSEcCtD
Sorafenib—PDGFRA—liver—malaria	0.000242	0.00292	CbGeAlD
Sorafenib—Erythema multiforme—Clindamycin—malaria	0.000241	0.00221	CcSEcCtD
Sorafenib—PDGFRB—blood—malaria	0.000241	0.00292	CbGeAlD
Sorafenib—CYP2C19—hematopoietic system—malaria	0.000241	0.00292	CbGeAlD
Sorafenib—KIT—bone marrow—malaria	0.000239	0.00289	CbGeAlD
Sorafenib—Thrombocytopenia—Sulfadiazine—malaria	0.000238	0.00219	CcSEcCtD
Sorafenib—MKNK2—brain—malaria	0.000238	0.00288	CbGeAlD
Sorafenib—CYP3A7-CYP3A51P—liver—malaria	0.000238	0.00287	CbGeAlD
Sorafenib—Hepatobiliary disease—Pentoxifylline—malaria	0.000238	0.00218	CcSEcCtD
Sorafenib—ABCC4—kidney—malaria	0.000238	0.00287	CbGeAlD
Sorafenib—Epistaxis—Pentoxifylline—malaria	0.000237	0.00217	CcSEcCtD
Sorafenib—Flushing—Clindamycin—malaria	0.000237	0.00217	CcSEcCtD
Sorafenib—Erythema multiforme—Quinine—malaria	0.000237	0.00217	CcSEcCtD
Sorafenib—Erythema multiforme—Quinidine—malaria	0.000237	0.00217	CcSEcCtD
Sorafenib—MKNK1—brain—malaria	0.000235	0.00284	CbGeAlD
Sorafenib—Tinnitus—Quinidine—malaria	0.000233	0.00214	CcSEcCtD
Sorafenib—Tinnitus—Quinine—malaria	0.000233	0.00214	CcSEcCtD
Sorafenib—PDGFRB—bone marrow—malaria	0.000233	0.00282	CbGeAlD
Sorafenib—Vomiting—Proguanil—malaria	0.000233	0.00214	CcSEcCtD
Sorafenib—Cardiac disorder—Quinine—malaria	0.000232	0.00213	CcSEcCtD
Sorafenib—Flushing—Quinine—malaria	0.000232	0.00213	CcSEcCtD
Sorafenib—Flushing—Quinidine—malaria	0.000232	0.00213	CcSEcCtD
Sorafenib—Cardiac disorder—Quinidine—malaria	0.000232	0.00213	CcSEcCtD
Sorafenib—RET—brain—malaria	0.000232	0.00281	CbGeAlD
Sorafenib—Anorexia—Sulfadiazine—malaria	0.000232	0.00213	CcSEcCtD
Sorafenib—Rash—Proguanil—malaria	0.000231	0.00212	CcSEcCtD
Sorafenib—Dermatitis—Proguanil—malaria	0.000231	0.00212	CcSEcCtD
Sorafenib—UGT1A1—liver—malaria	0.00023	0.00279	CbGeAlD
Sorafenib—ABCC2—kidney—malaria	0.00023	0.00278	CbGeAlD
Sorafenib—Headache—Proguanil—malaria	0.00023	0.00211	CcSEcCtD
Sorafenib—Erythema—Dapsone—malaria	0.00023	0.00211	CcSEcCtD
Sorafenib—Haemoglobin—Quinidine barbiturate—malaria	0.000227	0.00208	CcSEcCtD
Sorafenib—Haemoglobin—Pentoxifylline—malaria	0.000227	0.00208	CcSEcCtD
Sorafenib—Immune system disorder—Quinidine—malaria	0.000226	0.00208	CcSEcCtD
Sorafenib—Immune system disorder—Quinine—malaria	0.000226	0.00208	CcSEcCtD
Sorafenib—Haemorrhage—Quinidine barbiturate—malaria	0.000226	0.00207	CcSEcCtD
Sorafenib—Mediastinal disorder—Quinidine—malaria	0.000226	0.00207	CcSEcCtD
Sorafenib—Mediastinal disorder—Quinine—malaria	0.000226	0.00207	CcSEcCtD
Sorafenib—Haemorrhage—Pentoxifylline—malaria	0.000226	0.00207	CcSEcCtD
Sorafenib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000223	0.00205	CcSEcCtD
Sorafenib—Erythema—Clindamycin—malaria	0.000222	0.00204	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000222	0.00204	CcSEcCtD
Sorafenib—Urethral disorder—Quinidine barbiturate—malaria	0.000222	0.00203	CcSEcCtD
Sorafenib—Mental disorder—Quinine—malaria	0.000219	0.00201	CcSEcCtD
Sorafenib—Mental disorder—Quinidine—malaria	0.000219	0.00201	CcSEcCtD
Sorafenib—Malnutrition—Quinine—malaria	0.000218	0.002	CcSEcCtD
Sorafenib—Erythema—Quinidine—malaria	0.000218	0.002	CcSEcCtD
Sorafenib—Erythema—Quinine—malaria	0.000218	0.002	CcSEcCtD
Sorafenib—Malnutrition—Quinidine—malaria	0.000218	0.002	CcSEcCtD
Sorafenib—MAP2K5—liver—malaria	0.000218	0.00264	CbGeAlD
Sorafenib—KDR—liver—malaria	0.000218	0.00264	CbGeAlD
Sorafenib—Nausea—Proguanil—malaria	0.000218	0.002	CcSEcCtD
Sorafenib—Dysgeusia—Clindamycin—malaria	0.000218	0.002	CcSEcCtD
Sorafenib—RALBP1—brain—malaria	0.000215	0.0026	CbGeAlD
Sorafenib—ABCG2—saliva-secreting gland—malaria	0.000214	0.00259	CbGeAlD
Sorafenib—Erythema multiforme—Quinidine barbiturate—malaria	0.000214	0.00196	CcSEcCtD
Sorafenib—Muscle spasms—Clindamycin—malaria	0.000214	0.00196	CcSEcCtD
Sorafenib—CSF1R—liver—malaria	0.000213	0.00257	CbGeAlD
Sorafenib—Decreased appetite—Sulfadiazine—malaria	0.000212	0.00194	CcSEcCtD
Sorafenib—Tinnitus—Quinidine barbiturate—malaria	0.000211	0.00193	CcSEcCtD
Sorafenib—CYP2C8—hematopoietic system—malaria	0.00021	0.00254	CbGeAlD
Sorafenib—Gastrointestinal disorder—Sulfadiazine—malaria	0.00021	0.00193	CcSEcCtD
Sorafenib—Flushing—Quinidine barbiturate—malaria	0.00021	0.00192	CcSEcCtD
Sorafenib—Cardiac disorder—Quinidine barbiturate—malaria	0.00021	0.00192	CcSEcCtD
Sorafenib—Flushing—Pentoxifylline—malaria	0.000209	0.00192	CcSEcCtD
Sorafenib—Anaemia—Clindamycin—malaria	0.000205	0.00188	CcSEcCtD
Sorafenib—FLT1—brain—malaria	0.000205	0.00247	CbGeAlD
Sorafenib—Immune system disorder—Quinidine barbiturate—malaria	0.000204	0.00187	CcSEcCtD
Sorafenib—Immune system disorder—Pentoxifylline—malaria	0.000204	0.00187	CcSEcCtD
Sorafenib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000204	0.00187	CcSEcCtD
Sorafenib—RAF1—brain—malaria	0.000203	0.00246	CbGeAlD
Sorafenib—EPHB6—brain—malaria	0.000202	0.00244	CbGeAlD
Sorafenib—ABCC4—digestive system—malaria	0.000202	0.00244	CbGeAlD
Sorafenib—Arrhythmia—Pentoxifylline—malaria	0.000202	0.00185	CcSEcCtD
Sorafenib—HTR2B—digestive system—malaria	0.000201	0.00242	CbGeAlD
Sorafenib—Cough—Dapsone—malaria	0.0002	0.00184	CcSEcCtD
Sorafenib—Angioedema—Quinine—malaria	0.000199	0.00183	CcSEcCtD
Sorafenib—Angioedema—Quinidine—malaria	0.000199	0.00183	CcSEcCtD
Sorafenib—Gastrointestinal pain—Sulfadiazine—malaria	0.000199	0.00183	CcSEcCtD
Sorafenib—Leukopenia—Clindamycin—malaria	0.000199	0.00183	CcSEcCtD
Sorafenib—Mental disorder—Quinidine barbiturate—malaria	0.000198	0.00182	CcSEcCtD
Sorafenib—CYP1A2—hematopoietic system—malaria	0.000197	0.00238	CbGeAlD
Sorafenib—Malnutrition—Quinidine barbiturate—malaria	0.000197	0.00181	CcSEcCtD
Sorafenib—Erythema—Quinidine barbiturate—malaria	0.000197	0.00181	CcSEcCtD
Sorafenib—Erythema—Pentoxifylline—malaria	0.000196	0.0018	CcSEcCtD
Sorafenib—Syncope—Quinine—malaria	0.000195	0.00179	CcSEcCtD
Sorafenib—Syncope—Quinidine—malaria	0.000195	0.00179	CcSEcCtD
Sorafenib—ABCC2—digestive system—malaria	0.000195	0.00236	CbGeAlD
Sorafenib—Leukopenia—Quinidine—malaria	0.000195	0.00179	CcSEcCtD
Sorafenib—Leukopenia—Quinine—malaria	0.000195	0.00179	CcSEcCtD
Sorafenib—STK10—brain—malaria	0.000194	0.00234	CbGeAlD
Sorafenib—Urticaria—Sulfadiazine—malaria	0.000193	0.00178	CcSEcCtD
Sorafenib—KIT—liver—malaria	0.000193	0.00234	CbGeAlD
Sorafenib—Body temperature increased—Sulfadiazine—malaria	0.000193	0.00177	CcSEcCtD
Sorafenib—Abdominal pain—Sulfadiazine—malaria	0.000193	0.00177	CcSEcCtD
Sorafenib—Dysgeusia—Pentoxifylline—malaria	0.000192	0.00176	CcSEcCtD
Sorafenib—ABCC4—blood—malaria	0.000192	0.00232	CbGeAlD
Sorafenib—Hypertension—Clindamycin—malaria	0.000192	0.00176	CcSEcCtD
Sorafenib—PDGFRA—brain—malaria	0.000192	0.00232	CbGeAlD
Sorafenib—Loss of consciousness—Quinidine—malaria	0.000192	0.00176	CcSEcCtD
Sorafenib—Loss of consciousness—Quinine—malaria	0.000192	0.00176	CcSEcCtD
Sorafenib—HTR2B—blood—malaria	0.000191	0.00231	CbGeAlD
Sorafenib—CYP3A5—hematopoietic system—malaria	0.00019	0.0023	CbGeAlD
Sorafenib—CYP2B6—hematopoietic system—malaria	0.000189	0.00228	CbGeAlD
Sorafenib—Muscle spasms—Pentoxifylline—malaria	0.000189	0.00173	CcSEcCtD
Sorafenib—PDGFRB—liver—malaria	0.000189	0.00228	CbGeAlD
Sorafenib—CYP2C9—hematopoietic system—malaria	0.000187	0.00226	CbGeAlD
Sorafenib—ABCC2—blood—malaria	0.000186	0.00225	CbGeAlD
Sorafenib—ABCC4—bone marrow—malaria	0.000186	0.00225	CbGeAlD
Sorafenib—Myalgia—Quinine—malaria	0.000186	0.0017	CcSEcCtD
Sorafenib—Myalgia—Quinidine—malaria	0.000186	0.0017	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000184	0.00169	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000184	0.00169	CcSEcCtD
Sorafenib—ABCB1—blood plasma—malaria	0.000183	0.00221	CbGeAlD
Sorafenib—Anaemia—Pentoxifylline—malaria	0.000182	0.00167	CcSEcCtD
Sorafenib—Anaphylactic shock—Clindamycin—malaria	0.000181	0.00166	CcSEcCtD
Sorafenib—Angioedema—Quinidine barbiturate—malaria	0.00018	0.00165	CcSEcCtD
Sorafenib—Angioedema—Pentoxifylline—malaria	0.000179	0.00165	CcSEcCtD
Sorafenib—Hypersensitivity—Sulfadiazine—malaria	0.000179	0.00165	CcSEcCtD
Sorafenib—Thrombocytopenia—Clindamycin—malaria	0.000178	0.00163	CcSEcCtD
Sorafenib—Syncope—Quinidine barbiturate—malaria	0.000176	0.00162	CcSEcCtD
Sorafenib—Leukopenia—Quinidine barbiturate—malaria	0.000176	0.00162	CcSEcCtD
Sorafenib—Leukopenia—Pentoxifylline—malaria	0.000176	0.00161	CcSEcCtD
Sorafenib—Shock—Quinine—malaria	0.000175	0.00161	CcSEcCtD
Sorafenib—Shock—Quinidine—malaria	0.000175	0.00161	CcSEcCtD
Sorafenib—Nervous system disorder—Quinidine—malaria	0.000174	0.0016	CcSEcCtD
Sorafenib—Nervous system disorder—Quinine—malaria	0.000174	0.0016	CcSEcCtD
Sorafenib—Thrombocytopenia—Quinidine—malaria	0.000174	0.0016	CcSEcCtD
Sorafenib—Thrombocytopenia—Quinine—malaria	0.000174	0.0016	CcSEcCtD
Sorafenib—MAP2K5—brain—malaria	0.000173	0.00209	CbGeAlD
Sorafenib—KDR—brain—malaria	0.000173	0.00209	CbGeAlD
Sorafenib—Loss of consciousness—Quinidine barbiturate—malaria	0.000173	0.00159	CcSEcCtD
Sorafenib—Skin disorder—Quinine—malaria	0.000173	0.00159	CcSEcCtD
Sorafenib—Skin disorder—Quinidine—malaria	0.000173	0.00159	CcSEcCtD
Sorafenib—CYP2C8—kidney—malaria	0.000173	0.00209	CbGeAlD
Sorafenib—Pruritus—Sulfadiazine—malaria	0.000172	0.00158	CcSEcCtD
Sorafenib—Anorexia—Quinine—malaria	0.00017	0.00156	CcSEcCtD
Sorafenib—Anorexia—Quinidine—malaria	0.00017	0.00156	CcSEcCtD
Sorafenib—Hypertension—Pentoxifylline—malaria	0.00017	0.00156	CcSEcCtD
Sorafenib—CSF1R—brain—malaria	0.000169	0.00204	CbGeAlD
Sorafenib—CYP2C19—digestive system—malaria	0.000168	0.00203	CbGeAlD
Sorafenib—Myalgia—Quinidine barbiturate—malaria	0.000167	0.00154	CcSEcCtD
Sorafenib—Arthralgia—Quinidine barbiturate—malaria	0.000167	0.00154	CcSEcCtD
Sorafenib—Myalgia—Pentoxifylline—malaria	0.000167	0.00153	CcSEcCtD
Sorafenib—Diarrhoea—Sulfadiazine—malaria	0.000167	0.00153	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000166	0.00153	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000166	0.00152	CcSEcCtD
Sorafenib—Dry mouth—Pentoxifylline—malaria	0.000164	0.0015	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Quinidine—malaria	0.000162	0.00149	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Quinine—malaria	0.000162	0.00149	CcSEcCtD
Sorafenib—Dyspnoea—Clindamycin—malaria	0.000162	0.00148	CcSEcCtD
Sorafenib—Anaphylactic shock—Pentoxifylline—malaria	0.00016	0.00147	CcSEcCtD
Sorafenib—CYP2C19—blood—malaria	0.00016	0.00193	CbGeAlD
Sorafenib—Dyspepsia—Clindamycin—malaria	0.00016	0.00146	CcSEcCtD
Sorafenib—Infection—Pentoxifylline—malaria	0.000159	0.00146	CcSEcCtD
Sorafenib—Dyspnoea—Quinine—malaria	0.000159	0.00146	CcSEcCtD
Sorafenib—Dyspnoea—Quinidine—malaria	0.000159	0.00146	CcSEcCtD
Sorafenib—Shock—Quinidine barbiturate—malaria	0.000158	0.00145	CcSEcCtD
Sorafenib—Shock—Pentoxifylline—malaria	0.000158	0.00145	CcSEcCtD
Sorafenib—Nervous system disorder—Quinidine barbiturate—malaria	0.000157	0.00144	CcSEcCtD
Sorafenib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000157	0.00144	CcSEcCtD
Sorafenib—Thrombocytopenia—Pentoxifylline—malaria	0.000157	0.00144	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Clindamycin—malaria	0.000157	0.00144	CcSEcCtD
Sorafenib—Fatigue—Clindamycin—malaria	0.000156	0.00143	CcSEcCtD
Sorafenib—Skin disorder—Quinidine barbiturate—malaria	0.000156	0.00143	CcSEcCtD
Sorafenib—CYP3A5—kidney—malaria	0.000156	0.00188	CbGeAlD
Sorafenib—Skin disorder—Pentoxifylline—malaria	0.000156	0.00143	CcSEcCtD
Sorafenib—Pain—Clindamycin—malaria	0.000155	0.00142	CcSEcCtD
Sorafenib—Constipation—Clindamycin—malaria	0.000155	0.00142	CcSEcCtD
Sorafenib—Vomiting—Sulfadiazine—malaria	0.000155	0.00142	CcSEcCtD
Sorafenib—CYP2B6—kidney—malaria	0.000155	0.00187	CbGeAlD
Sorafenib—Decreased appetite—Quinine—malaria	0.000155	0.00142	CcSEcCtD
Sorafenib—Decreased appetite—Quinidine—malaria	0.000155	0.00142	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Quinidine—malaria	0.000154	0.00141	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Quinine—malaria	0.000154	0.00141	CcSEcCtD
Sorafenib—Rash—Sulfadiazine—malaria	0.000154	0.00141	CcSEcCtD
Sorafenib—Dermatitis—Sulfadiazine—malaria	0.000153	0.00141	CcSEcCtD
Sorafenib—Gastrointestinal pain—Dapsone—malaria	0.000153	0.00141	CcSEcCtD
Sorafenib—KIT—brain—malaria	0.000153	0.00185	CbGeAlD
Sorafenib—Anorexia—Quinidine barbiturate—malaria	0.000153	0.0014	CcSEcCtD
Sorafenib—Anorexia—Pentoxifylline—malaria	0.000153	0.0014	CcSEcCtD
Sorafenib—Headache—Sulfadiazine—malaria	0.000153	0.0014	CcSEcCtD
Sorafenib—ABCC4—liver—malaria	0.00015	0.00182	CbGeAlD
Sorafenib—PDGFRB—brain—malaria	0.00015	0.00181	CbGeAlD
Sorafenib—Gastrointestinal pain—Clindamycin—malaria	0.000148	0.00136	CcSEcCtD
Sorafenib—Abdominal pain—Dapsone—malaria	0.000148	0.00136	CcSEcCtD
Sorafenib—Body temperature increased—Dapsone—malaria	0.000148	0.00136	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000146	0.00134	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000146	0.00134	CcSEcCtD
Sorafenib—Gastrointestinal pain—Quinidine—malaria	0.000145	0.00133	CcSEcCtD
Sorafenib—Gastrointestinal pain—Quinine—malaria	0.000145	0.00133	CcSEcCtD
Sorafenib—ABCC2—liver—malaria	0.000145	0.00176	CbGeAlD
Sorafenib—Nausea—Sulfadiazine—malaria	0.000145	0.00133	CcSEcCtD
Sorafenib—Urticaria—Clindamycin—malaria	0.000144	0.00132	CcSEcCtD
Sorafenib—Body temperature increased—Clindamycin—malaria	0.000143	0.00132	CcSEcCtD
Sorafenib—Abdominal pain—Clindamycin—malaria	0.000143	0.00132	CcSEcCtD
Sorafenib—Dyspnoea—Quinidine barbiturate—malaria	0.000143	0.00131	CcSEcCtD
Sorafenib—Dyspnoea—Pentoxifylline—malaria	0.000143	0.00131	CcSEcCtD
Sorafenib—CYP3A4—hematopoietic system—malaria	0.000143	0.00172	CbGeAlD
Sorafenib—Urticaria—Quinidine—malaria	0.000141	0.0013	CcSEcCtD
Sorafenib—Urticaria—Quinine—malaria	0.000141	0.0013	CcSEcCtD
Sorafenib—Dyspepsia—Pentoxifylline—malaria	0.000141	0.00129	CcSEcCtD
Sorafenib—Body temperature increased—Quinine—malaria	0.000141	0.00129	CcSEcCtD
Sorafenib—Abdominal pain—Quinine—malaria	0.000141	0.00129	CcSEcCtD
Sorafenib—Body temperature increased—Quinidine—malaria	0.000141	0.00129	CcSEcCtD
Sorafenib—Abdominal pain—Quinidine—malaria	0.000141	0.00129	CcSEcCtD
Sorafenib—CYP2D6—hematopoietic system—malaria	0.00014	0.0017	CbGeAlD
Sorafenib—Decreased appetite—Quinidine barbiturate—malaria	0.00014	0.00128	CcSEcCtD
Sorafenib—CYP2C8—blood—malaria	0.000139	0.00169	CbGeAlD
Sorafenib—Decreased appetite—Pentoxifylline—malaria	0.000139	0.00128	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000139	0.00127	CcSEcCtD
Sorafenib—Constipation—Quinidine barbiturate—malaria	0.000137	0.00126	CcSEcCtD
Sorafenib—Pain—Quinidine barbiturate—malaria	0.000137	0.00126	CcSEcCtD
Sorafenib—Constipation—Pentoxifylline—malaria	0.000137	0.00126	CcSEcCtD
Sorafenib—CYP1A2—digestive system—malaria	0.000137	0.00166	CbGeAlD
Sorafenib—ABCG2—blood—malaria	0.000136	0.00164	CbGeAlD
Sorafenib—Hypersensitivity—Clindamycin—malaria	0.000134	0.00123	CcSEcCtD
Sorafenib—CYP3A5—digestive system—malaria	0.000132	0.0016	CbGeAlD
Sorafenib—CYP2B6—digestive system—malaria	0.000131	0.00159	CbGeAlD
Sorafenib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000131	0.0012	CcSEcCtD
Sorafenib—ABCG2—bone marrow—malaria	0.000131	0.00159	CbGeAlD
Sorafenib—Hypersensitivity—Quinine—malaria	0.000131	0.0012	CcSEcCtD
Sorafenib—Hypersensitivity—Quinidine—malaria	0.000131	0.0012	CcSEcCtD
Sorafenib—Gastrointestinal pain—Pentoxifylline—malaria	0.000131	0.0012	CcSEcCtD
Sorafenib—CYP1A2—blood—malaria	0.00013	0.00158	CbGeAlD
Sorafenib—Asthenia—Clindamycin—malaria	0.00013	0.00119	CcSEcCtD
Sorafenib—CYP2C9—digestive system—malaria	0.00013	0.00157	CbGeAlD
Sorafenib—Pruritus—Clindamycin—malaria	0.000128	0.00118	CcSEcCtD
Sorafenib—Asthenia—Quinine—malaria	0.000128	0.00117	CcSEcCtD
Sorafenib—Asthenia—Quinidine—malaria	0.000128	0.00117	CcSEcCtD
Sorafenib—Urticaria—Quinidine barbiturate—malaria	0.000128	0.00117	CcSEcCtD
Sorafenib—Urticaria—Pentoxifylline—malaria	0.000127	0.00117	CcSEcCtD
Sorafenib—Abdominal pain—Quinidine barbiturate—malaria	0.000127	0.00116	CcSEcCtD
Sorafenib—Body temperature increased—Quinidine barbiturate—malaria	0.000127	0.00116	CcSEcCtD
Sorafenib—Body temperature increased—Pentoxifylline—malaria	0.000127	0.00116	CcSEcCtD
Sorafenib—Abdominal pain—Pentoxifylline—malaria	0.000127	0.00116	CcSEcCtD
Sorafenib—HTR2C—brain—malaria	0.000126	0.00153	CbGeAlD
Sorafenib—Pruritus—Quinidine—malaria	0.000126	0.00115	CcSEcCtD
Sorafenib—Pruritus—Quinine—malaria	0.000126	0.00115	CcSEcCtD
Sorafenib—CYP3A5—blood—malaria	0.000126	0.00152	CbGeAlD
Sorafenib—CYP2B6—blood—malaria	0.000125	0.00151	CbGeAlD
Sorafenib—CYP2C19—liver—malaria	0.000125	0.00151	CbGeAlD
Sorafenib—Diarrhoea—Clindamycin—malaria	0.000124	0.00114	CcSEcCtD
Sorafenib—CYP2C9—blood—malaria	0.000124	0.0015	CbGeAlD
Sorafenib—Diarrhoea—Quinine—malaria	0.000122	0.00112	CcSEcCtD
Sorafenib—Diarrhoea—Quinidine—malaria	0.000122	0.00112	CcSEcCtD
Sorafenib—Dizziness—Clindamycin—malaria	0.00012	0.0011	CcSEcCtD
Sorafenib—Vomiting—Dapsone—malaria	0.000119	0.00109	CcSEcCtD
Sorafenib—ABCC4—brain—malaria	0.000119	0.00144	CbGeAlD
Sorafenib—HTR2B—brain—malaria	0.000119	0.00143	CbGeAlD
Sorafenib—Hypersensitivity—Quinidine barbiturate—malaria	0.000118	0.00109	CcSEcCtD
Sorafenib—Hypersensitivity—Pentoxifylline—malaria	0.000118	0.00108	CcSEcCtD
Sorafenib—Dizziness—Quinidine—malaria	0.000118	0.00108	CcSEcCtD
Sorafenib—Dizziness—Quinine—malaria	0.000118	0.00108	CcSEcCtD
Sorafenib—Headache—Dapsone—malaria	0.000117	0.00108	CcSEcCtD
Sorafenib—CYP3A4—kidney—malaria	0.000117	0.00141	CbGeAlD
Sorafenib—Vomiting—Clindamycin—malaria	0.000115	0.00106	CcSEcCtD
Sorafenib—Asthenia—Quinidine barbiturate—malaria	0.000115	0.00106	CcSEcCtD
Sorafenib—CYP2D6—kidney—malaria	0.000115	0.00139	CbGeAlD
Sorafenib—Asthenia—Pentoxifylline—malaria	0.000115	0.00106	CcSEcCtD
Sorafenib—Rash—Clindamycin—malaria	0.000114	0.00105	CcSEcCtD
Sorafenib—Dermatitis—Clindamycin—malaria	0.000114	0.00105	CcSEcCtD
Sorafenib—Headache—Clindamycin—malaria	0.000114	0.00104	CcSEcCtD
Sorafenib—Pruritus—Quinidine barbiturate—malaria	0.000114	0.00104	CcSEcCtD
Sorafenib—Pruritus—Pentoxifylline—malaria	0.000113	0.00104	CcSEcCtD
Sorafenib—Vomiting—Quinidine—malaria	0.000113	0.00104	CcSEcCtD
Sorafenib—Vomiting—Quinine—malaria	0.000113	0.00104	CcSEcCtD
Sorafenib—Rash—Quinine—malaria	0.000112	0.00103	CcSEcCtD
Sorafenib—Rash—Quinidine—malaria	0.000112	0.00103	CcSEcCtD
Sorafenib—Dermatitis—Quinine—malaria	0.000112	0.00103	CcSEcCtD
Sorafenib—Dermatitis—Quinidine—malaria	0.000112	0.00103	CcSEcCtD
Sorafenib—Headache—Quinine—malaria	0.000111	0.00102	CcSEcCtD
Sorafenib—Headache—Quinidine—malaria	0.000111	0.00102	CcSEcCtD
Sorafenib—Nausea—Dapsone—malaria	0.000111	0.00102	CcSEcCtD
Sorafenib—Diarrhoea—Quinidine barbiturate—malaria	0.00011	0.00101	CcSEcCtD
Sorafenib—Diarrhoea—Pentoxifylline—malaria	0.00011	0.00101	CcSEcCtD
Sorafenib—CYP2C8—liver—malaria	0.000109	0.00132	CbGeAlD
Sorafenib—Nausea—Clindamycin—malaria	0.000108	0.000988	CcSEcCtD
Sorafenib—Dizziness—Quinidine barbiturate—malaria	0.000106	0.000974	CcSEcCtD
Sorafenib—ABCG2—liver—malaria	0.000106	0.00128	CbGeAlD
Sorafenib—Dizziness—Pentoxifylline—malaria	0.000106	0.000972	CcSEcCtD
Sorafenib—Nausea—Quinine—malaria	0.000106	0.00097	CcSEcCtD
Sorafenib—Nausea—Quinidine—malaria	0.000106	0.00097	CcSEcCtD
Sorafenib—Vomiting—Quinidine barbiturate—malaria	0.000102	0.000937	CcSEcCtD
Sorafenib—CYP1A2—liver—malaria	0.000102	0.00123	CbGeAlD
Sorafenib—Vomiting—Pentoxifylline—malaria	0.000102	0.000935	CcSEcCtD
Sorafenib—Rash—Quinidine barbiturate—malaria	0.000101	0.000929	CcSEcCtD
Sorafenib—Dermatitis—Quinidine barbiturate—malaria	0.000101	0.000928	CcSEcCtD
Sorafenib—Rash—Pentoxifylline—malaria	0.000101	0.000927	CcSEcCtD
Sorafenib—Dermatitis—Pentoxifylline—malaria	0.000101	0.000926	CcSEcCtD
Sorafenib—ABCB1—hematopoietic system—malaria	0.000101	0.00122	CbGeAlD
Sorafenib—Headache—Quinidine barbiturate—malaria	0.000101	0.000923	CcSEcCtD
Sorafenib—Headache—Pentoxifylline—malaria	0.0001	0.000921	CcSEcCtD
Sorafenib—CYP3A4—digestive system—malaria	9.91e-05	0.0012	CbGeAlD
Sorafenib—CYP3A5—liver—malaria	9.84e-05	0.00119	CbGeAlD
Sorafenib—CYP2B6—liver—malaria	9.78e-05	0.00118	CbGeAlD
Sorafenib—CYP2D6—digestive system—malaria	9.76e-05	0.00118	CbGeAlD
Sorafenib—CYP2C9—liver—malaria	9.69e-05	0.00117	CbGeAlD
Sorafenib—Nausea—Quinidine barbiturate—malaria	9.54e-05	0.000875	CcSEcCtD
Sorafenib—Nausea—Pentoxifylline—malaria	9.52e-05	0.000874	CcSEcCtD
Sorafenib—CYP3A4—blood—malaria	9.45e-05	0.00114	CbGeAlD
Sorafenib—CYP2D6—blood—malaria	9.29e-05	0.00112	CbGeAlD
Sorafenib—CYP2C8—brain—malaria	8.65e-05	0.00105	CbGeAlD
Sorafenib—ABCG2—brain—malaria	8.41e-05	0.00102	CbGeAlD
Sorafenib—ABCB1—kidney—malaria	8.27e-05	0.001	CbGeAlD
Sorafenib—CYP2B6—brain—malaria	7.76e-05	0.000938	CbGeAlD
Sorafenib—CYP3A4—liver—malaria	7.39e-05	0.000893	CbGeAlD
Sorafenib—CYP2D6—liver—malaria	7.27e-05	0.000879	CbGeAlD
Sorafenib—ABCB1—digestive system—malaria	7.02e-05	0.000849	CbGeAlD
Sorafenib—ABCB1—blood—malaria	6.69e-05	0.000808	CbGeAlD
Sorafenib—ABCB1—bone marrow—malaria	6.47e-05	0.000782	CbGeAlD
Sorafenib—CYP2D6—brain—malaria	5.77e-05	0.000697	CbGeAlD
Sorafenib—ABCB1—liver—malaria	5.23e-05	0.000632	CbGeAlD
Sorafenib—ABCB1—brain—malaria	4.15e-05	0.000502	CbGeAlD
Sorafenib—ABCB1—Metabolism—SLC4A1—malaria	1.04e-05	0.000173	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.03e-05	0.000171	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TLR9—malaria	1.02e-05	0.00017	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—ICAM1—malaria	1.02e-05	0.00017	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL18—malaria	1.02e-05	0.00017	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD40LG—malaria	1.02e-05	0.000169	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—HBB—malaria	1.01e-05	0.000169	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD8A—malaria	1.01e-05	0.000167	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CRP—malaria	1e-05	0.000167	CbGpPWpGaD
Sorafenib—KIT—Immune System—CRP—malaria	1e-05	0.000167	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—DECR1—malaria	1e-05	0.000166	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—CD4—malaria	9.91e-06	0.000165	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—HPGDS—malaria	9.89e-06	0.000165	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—HPGDS—malaria	9.8e-06	0.000163	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—SLC4A1—malaria	9.78e-06	0.000163	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TNF—malaria	9.78e-06	0.000163	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—DECR1—malaria	9.76e-06	0.000162	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—DHODH—malaria	9.75e-06	0.000162	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—SLC4A1—malaria	9.7e-06	0.000161	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-B—malaria	9.67e-06	0.000161	CbGpPWpGaD
Sorafenib—KIT—Immune System—TLR4—malaria	9.61e-06	0.00016	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—TLR4—malaria	9.61e-06	0.00016	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	9.59e-06	0.00016	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—CD4—malaria	9.52e-06	0.000158	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CRP—malaria	9.51e-06	0.000158	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—G6PD—malaria	9.51e-06	0.000158	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CRP—malaria	9.49e-06	0.000158	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD36—malaria	9.48e-06	0.000158	CbGpPWpGaD
Sorafenib—CDK7—Disease—CD4—malaria	9.48e-06	0.000158	CbGpPWpGaD
Sorafenib—FGFR1—Axon guidance—IL6—malaria	9.47e-06	0.000158	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—IL6—malaria	9.4e-06	0.000156	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—G6PD—malaria	9.29e-06	0.000155	CbGpPWpGaD
Sorafenib—BRAF—Disease—NOS2—malaria	9.27e-06	0.000154	CbGpPWpGaD
Sorafenib—KIT—Immune System—ICAM1—malaria	9.21e-06	0.000153	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—ICAM1—malaria	9.21e-06	0.000153	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—DECR1—malaria	9.2e-06	0.000153	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—IL6—malaria	9.18e-06	0.000153	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—DHFR—malaria	9.18e-06	0.000153	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—TLR4—malaria	9.12e-06	0.000152	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—DECR1—malaria	9.12e-06	0.000152	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—TLR4—malaria	9.1e-06	0.000151	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL18—malaria	9.1e-06	0.000151	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—DHFR—malaria	9.09e-06	0.000151	CbGpPWpGaD
Sorafenib—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	9.09e-06	0.000151	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—SCARB1—malaria	9.08e-06	0.000151	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD40LG—malaria	9.06e-06	0.000151	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—HBB—malaria	9.04e-06	0.000151	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PKLR—malaria	9.03e-06	0.00015	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—IL2—malaria	9.03e-06	0.00015	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—SCARB1—malaria	9e-06	0.00015	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD8A—malaria	8.96e-06	0.000149	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—CD4—malaria	8.83e-06	0.000147	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—HBB—malaria	8.83e-06	0.000147	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	8.8e-06	0.000147	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—ICAM1—malaria	8.74e-06	0.000146	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—ICAM1—malaria	8.72e-06	0.000145	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—IL2—malaria	8.67e-06	0.000144	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-B—malaria	8.62e-06	0.000143	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CRP—malaria	8.55e-06	0.000142	CbGpPWpGaD
Sorafenib—RAF1—Cytokine Signaling in Immune system—IL6—malaria	8.52e-06	0.000142	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—CD4—malaria	8.48e-06	0.000141	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD36—malaria	8.45e-06	0.000141	CbGpPWpGaD
Sorafenib—KIT—Disease—NOS2—malaria	8.44e-06	0.00014	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—IL6—malaria	8.38e-06	0.000139	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TNF—malaria	8.37e-06	0.000139	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—HBB—malaria	8.32e-06	0.000138	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—SLC4A1—malaria	8.29e-06	0.000138	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—HBB—malaria	8.25e-06	0.000137	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—KDR—malaria	8.22e-06	0.000137	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—TLR4—malaria	8.19e-06	0.000136	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PKLR—malaria	8.06e-06	0.000134	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—G6PD—malaria	8.05e-06	0.000134	CbGpPWpGaD
Sorafenib—FGFR1—Disease—NOS2—malaria	8.01e-06	0.000133	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—NOS2—malaria	7.99e-06	0.000133	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	7.94e-06	0.000132	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—IL6—malaria	7.89e-06	0.000131	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PKLR—malaria	7.87e-06	0.000131	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—ICAM1—malaria	7.86e-06	0.000131	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—IL2—malaria	7.81e-06	0.00013	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—DECR1—malaria	7.79e-06	0.00013	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IFNG—malaria	7.77e-06	0.000129	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CRP—malaria	7.62e-06	0.000127	CbGpPWpGaD
Sorafenib—RAF1—Axon guidance—IL6—malaria	7.58e-06	0.000126	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—DHODH—malaria	7.52e-06	0.000125	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CD4—malaria	7.51e-06	0.000125	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PKLR—malaria	7.41e-06	0.000123	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PKLR—malaria	7.35e-06	0.000122	CbGpPWpGaD
Sorafenib—RAF1—Immune System—TLR4—malaria	7.3e-06	0.000122	CbGpPWpGaD
Sorafenib—MKNK1—Disease—IL6—malaria	7.28e-06	0.000121	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—HPGDS—malaria	7.25e-06	0.000121	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—NOS2—malaria	7.2e-06	0.00012	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—G6PD—malaria	7.18e-06	0.00012	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	7.09e-06	0.000118	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—HPGDS—malaria	7.09e-06	0.000118	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—HBB—malaria	7.05e-06	0.000117	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—G6PD—malaria	7.01e-06	0.000117	CbGpPWpGaD
Sorafenib—KIT—Immune System—IFNG—malaria	7.01e-06	0.000117	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IFNG—malaria	7.01e-06	0.000117	CbGpPWpGaD
Sorafenib—RAF1—Immune System—ICAM1—malaria	7e-06	0.000117	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—IL6—malaria	6.97e-06	0.000116	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL1B—malaria	6.93e-06	0.000115	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL2—malaria	6.91e-06	0.000115	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—KDR—malaria	6.89e-06	0.000115	CbGpPWpGaD
Sorafenib—BRAF—Disease—CD4—malaria	6.87e-06	0.000114	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—KDR—malaria	6.82e-06	0.000114	CbGpPWpGaD
Sorafenib—KIT—Immune System—CD4—malaria	6.77e-06	0.000113	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CD4—malaria	6.77e-06	0.000113	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	6.76e-06	0.000113	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—IL6—malaria	6.75e-06	0.000112	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—DHFR—malaria	6.73e-06	0.000112	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CD36—malaria	6.72e-06	0.000112	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CD36—malaria	6.72e-06	0.000112	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TNF—malaria	6.7e-06	0.000112	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—SCARB1—malaria	6.66e-06	0.000111	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IFNG—malaria	6.65e-06	0.000111	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IFNG—malaria	6.63e-06	0.00011	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—G6PD—malaria	6.61e-06	0.00011	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—DHFR—malaria	6.57e-06	0.000109	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—G6PD—malaria	6.55e-06	0.000109	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—SCARB1—malaria	6.51e-06	0.000108	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	6.46e-06	0.000108	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CD4—malaria	6.42e-06	0.000107	CbGpPWpGaD
Sorafenib—RAF1—Disease—NOS2—malaria	6.41e-06	0.000107	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CD4—malaria	6.41e-06	0.000107	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—SLC4A1—malaria	6.4e-06	0.000106	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—IL6—malaria	6.29e-06	0.000105	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—IL6—malaria	6.29e-06	0.000105	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PKLR—malaria	6.28e-06	0.000105	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL1B—malaria	6.25e-06	0.000104	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL1B—malaria	6.25e-06	0.000104	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—IL6—malaria	6.25e-06	0.000104	CbGpPWpGaD
Sorafenib—KIT—Disease—CD4—malaria	6.25e-06	0.000104	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL2—malaria	6.23e-06	0.000104	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL2—malaria	6.23e-06	0.000104	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—KDR—malaria	6.21e-06	0.000103	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—KDR—malaria	6.21e-06	0.000103	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—IL6—malaria	6.15e-06	0.000102	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—HPGDS—malaria	6.14e-06	0.000102	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—IL2—malaria	6.11e-06	0.000102	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—DECR1—malaria	6.01e-06	0.0001	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IFNG—malaria	5.98e-06	9.95e-05	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—IL6—malaria	5.97e-06	9.93e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—IL6—malaria	5.95e-06	9.91e-05	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL1B—malaria	5.93e-06	9.88e-05	CbGpPWpGaD
Sorafenib—FGFR1—Disease—CD4—malaria	5.93e-06	9.88e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL1B—malaria	5.92e-06	9.85e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—CD4—malaria	5.92e-06	9.85e-05	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL2—malaria	5.91e-06	9.84e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL2—malaria	5.9e-06	9.82e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—KDR—malaria	5.9e-06	9.82e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—KDR—malaria	5.88e-06	9.79e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD4—malaria	5.77e-06	9.61e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CD36—malaria	5.7e-06	9.49e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—DHFR—malaria	5.69e-06	9.48e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CD36—malaria	5.65e-06	9.4e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—SCARB1—malaria	5.64e-06	9.38e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—G6PD—malaria	5.6e-06	9.32e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—IL2—malaria	5.54e-06	9.23e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	5.52e-06	9.2e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—HPGDS—malaria	5.48e-06	9.12e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—HBB—malaria	5.44e-06	9.05e-05	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—IL6—malaria	5.41e-06	9.01e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—IL6—malaria	5.36e-06	8.92e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—HPGDS—malaria	5.35e-06	8.9e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL1B—malaria	5.33e-06	8.88e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—CD4—malaria	5.33e-06	8.87e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—IL2—malaria	5.33e-06	8.87e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IFNG—malaria	5.33e-06	8.87e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL2—malaria	5.31e-06	8.84e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—KDR—malaria	5.3e-06	8.82e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—IL2—malaria	5.19e-06	8.65e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—IL2—malaria	5.18e-06	8.63e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD4—malaria	5.15e-06	8.57e-05	CbGpPWpGaD
Sorafenib—CDK7—Disease—IL6—malaria	5.13e-06	8.54e-05	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—IL6—malaria	5.1e-06	8.48e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—DHFR—malaria	5.08e-06	8.46e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—KDR—malaria	5.05e-06	8.41e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—HPGDS—malaria	5.04e-06	8.39e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—SCARB1—malaria	5.03e-06	8.37e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—HPGDS—malaria	5e-06	8.32e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—DHFR—malaria	4.96e-06	8.26e-05	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—IL2—malaria	4.93e-06	8.2e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—SCARB1—malaria	4.91e-06	8.17e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PKLR—malaria	4.85e-06	8.07e-05	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—IL6—malaria	4.78e-06	7.95e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL1B—malaria	4.75e-06	7.91e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—CD4—malaria	4.75e-06	7.91e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL2—malaria	4.73e-06	7.88e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—KDR—malaria	4.72e-06	7.86e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—DHFR—malaria	4.67e-06	7.78e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—DHFR—malaria	4.63e-06	7.72e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—SCARB1—malaria	4.63e-06	7.7e-05	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—IL6—malaria	4.59e-06	7.64e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—SCARB1—malaria	4.59e-06	7.64e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—IL2—malaria	4.47e-06	7.45e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—IL2—malaria	4.47e-06	7.44e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—IL2—malaria	4.42e-06	7.37e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—G6PD—malaria	4.32e-06	7.19e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—HPGDS—malaria	4.27e-06	7.11e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CD36—malaria	4.18e-06	6.96e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CD36—malaria	4.08e-06	6.8e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—KDR—malaria	4.08e-06	6.79e-05	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL6—malaria	4.06e-06	6.76e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—IL2—malaria	4.03e-06	6.7e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—IL2—malaria	4.03e-06	6.7e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—DHFR—malaria	3.96e-06	6.59e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—SCARB1—malaria	3.92e-06	6.53e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—IL2—malaria	3.82e-06	6.36e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—IL2—malaria	3.81e-06	6.35e-05	CbGpPWpGaD
Sorafenib—BRAF—Disease—IL6—malaria	3.71e-06	6.18e-05	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL6—malaria	3.66e-06	6.1e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL6—malaria	3.66e-06	6.1e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CD36—malaria	3.54e-06	5.89e-05	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL6—malaria	3.47e-06	5.78e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL6—malaria	3.47e-06	5.77e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—IL2—malaria	3.43e-06	5.72e-05	CbGpPWpGaD
Sorafenib—KIT—Disease—IL6—malaria	3.38e-06	5.63e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—HPGDS—malaria	3.29e-06	5.49e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—IL2—malaria	3.28e-06	5.45e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—IL6—malaria	3.26e-06	5.43e-05	CbGpPWpGaD
Sorafenib—FGFR1—Disease—IL6—malaria	3.21e-06	5.34e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—IL6—malaria	3.2e-06	5.33e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CD36—malaria	3.16e-06	5.26e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—IL6—malaria	3.13e-06	5.22e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL6—malaria	3.12e-06	5.2e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CD36—malaria	3.08e-06	5.13e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—IL2—malaria	3.06e-06	5.1e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—DHFR—malaria	3.06e-06	5.09e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—IL6—malaria	3.05e-06	5.08e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—IL6—malaria	3.05e-06	5.07e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—SCARB1—malaria	3.02e-06	5.04e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CD36—malaria	2.9e-06	4.83e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—IL6—malaria	2.88e-06	4.8e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CD36—malaria	2.88e-06	4.79e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL6—malaria	2.78e-06	4.63e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—IL2—malaria	2.64e-06	4.4e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—IL6—malaria	2.63e-06	4.38e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—IL6—malaria	2.63e-06	4.37e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—IL6—malaria	2.6e-06	4.33e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—IL6—malaria	2.57e-06	4.28e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CD36—malaria	2.46e-06	4.1e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—IL6—malaria	2.37e-06	3.94e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—IL6—malaria	2.37e-06	3.94e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—IL6—malaria	2.25e-06	3.74e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—IL6—malaria	2.24e-06	3.73e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—IL6—malaria	2.02e-06	3.36e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—IL6—malaria	1.93e-06	3.21e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CD36—malaria	1.9e-06	3.16e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—IL6—malaria	1.8e-06	3e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—IL6—malaria	1.55e-06	2.59e-05	CbGpPWpGaD
